Announcement.

BIOMED-LUBLIN WYTWÓRNIA SUROWIC I SZCZEPIONEK SA (55/2017) Repayment by the Issuer of the arrangement obligations

The Management Board of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA ("Issuer", "Company") informs that on 22 September 2017 the following arrangement obligations were paid: - liabilities to creditors in Group 2 (public creditors) legal) - a total of PLN 468,793.31 for the repayment of the total contractual receivable The Issuer informed about deferring the repayment of the installment receivable due to PARP in the current report No. 52/2017 dated 21/09/2017. On repayment of the liability for the creditors in Group 5 (bondholders) in the amount of PLN 450,000, for repayment of 5% of the capital of bonds, the Issuer informed in the current report No. 54/2017 of 22/09/2017. Repayment of the above liabilities is the implementation of the arrangement with creditors concluded by the Company. The payment deadline is in line with the settlement proposals approved by the Court for the creditors. Legal basis - Article 17 (1) of the Regulation of the European Parliament and of the (EU) No 596/2014 (MAR).

Source: company website, investor relations, current and periodic reports.

ALL COMPANY ANNOUNCMENTS
Company information
Company name:Biomed-Lublin Wytwórnia Surowic i Szczepionek SA
ISIN:PLBMDLB00018
NIP:7122591951
Adress: ul. Uniwersytecka 10 20-029 Lublin
Phone:+48 81 5330926
website:www.biomed.lublin.pl

Copyright © 2017 PolandStockExchange
This website uses cookies (Regulations / Cookie Policy).